Caro-Vega, Yanink; Belaunzarán-Zamudio, Pablo F.; Crabtree-Ramírez, Brenda E.; Shepherd, Bryan E.; Grinsztejn, Beatriz; Wolff, Marcelo; Pape, Jean W.; Padgett, Denis; Gotuzzo Herencia, José Eduardo; McGowan, Catherine C.; Sierra-Madero, Juan G.
(Oxford University Press, 2018)
Background: Efavirenz (EFV) and boosted protease inhibitors (bPIs) are still the preferred options for firstline antiretroviral regimens (firstline ART) in Latin America and have comparable short-term efficacy. We assessed ...